Connect with us
Grifols and Pharma Mar reduced profits, while Reig Jofre, Faes Farma, Rovi and Almirall increased their profits between January and June. This last company has exceeded...
Grifols closed 2021 with a profit of $192 million (€182.3 million), compared with the $651 million (€618.5 million) recorded in 2020. Grifols recorded a turnover of...
The six listed pharmaceutical companies close the first quarter of 2022 with a stock market value of $16.7 billion (€15.1 billion). The biggest decline was registered...
The negative variation of the Spanish pharmaceutical sector contrasts with the positive performance of the Ibex35, which recorded a rise of 8% at the close of...
The Spanish multinational Grifols, specialized in the production of blood products, has continued to expand its network with the launch of the first integrated plasma supply...
In September, Grifols agreed to acquire the entire share capital of Tiancheng (Germany) Pharmaceutical Holdings AG for $1.3 billion (€1.1 billion), which holds 90% of the...
The bond proceeds will be used to finance the $1.3 billion (€1.1 billion) purchase of the entire share capital of Tiancheng Pharmaceutical Holdings, which in turn...
The performance of the pharmaceutical sector in the third quarter was worse than that of the Ibex35, the Spanish benchmark index, which fell by 0.3% in...
Grifols has assured that 87.93% of bondholders of its secured bonds, 81.01% of unsecured bonds, the required 93.82% of underwriters of its syndicated credit facility, and...
Grifols increases its profits in the first six months of the year. The Spanish multinational, which specializes in the production of plasma derivatives, achieved a profit...